[an error occurred while processing this directive]

高等学校化学研究 ›› 2018, Vol. 34 ›› Issue (1): 90-94.doi: 10.1007/s40242-018-7184-4

• Articles • 上一篇    下一篇

Synthesis, In vitro Coagulation Activities and Molecular Docking Studies on Three L-Histidine Amide Derivatives

HE Wei1, ZHAO Anran2, ZOU Jiajia1, LUO Xuan1, LIN Xiao3, WANG Lisheng1, LIN Cuiwu1   

  1. 1. School of Chemistry and Chemical Engineering, Nanning & Guangxi Colleges and Universities Key Laboratory of Applied Chemistry Technology and Resource Development, Guangxi University, Nanning 530004, P. R. China;
    2. Department of Chemistry, Cleveland State University, Cleveland, OH 44115, USA;
    3. Guangxi Key Laboratory of Traditional Chinese Medicine Quality Standards, Guangxi Institute of Traditional Medical and Pharmaceutical Sciences, Nanning 530022, P. R. China
  • 收稿日期:2017-05-23 出版日期:2018-02-01 发布日期:2018-01-20
  • 通讯作者: LIN Cuiwu,E-mail:Lincuiwu@163.com E-mail:Lincuiwu@163.com
  • 基金资助:
    Supported by the National Natural Science Foundation of China(No.21362001), the Project of the Guangxi Key Laboratory of Traditional Chinese Medicine Quality Standards, China(No.guizhongzhongkai201104) and the High Level Innovation Team and Outstanding Scholar Project of Guangxi Institutions of Higher Education, China(No.guijiaoren[2014]49).

Synthesis, In vitro Coagulation Activities and Molecular Docking Studies on Three L-Histidine Amide Derivatives

HE Wei1, ZHAO Anran2, ZOU Jiajia1, LUO Xuan1, LIN Xiao3, WANG Lisheng1, LIN Cuiwu1   

  1. 1. School of Chemistry and Chemical Engineering, Nanning & Guangxi Colleges and Universities Key Laboratory of Applied Chemistry Technology and Resource Development, Guangxi University, Nanning 530004, P. R. China;
    2. Department of Chemistry, Cleveland State University, Cleveland, OH 44115, USA;
    3. Guangxi Key Laboratory of Traditional Chinese Medicine Quality Standards, Guangxi Institute of Traditional Medical and Pharmaceutical Sciences, Nanning 530022, P. R. China
  • Received:2017-05-23 Online:2018-02-01 Published:2018-01-20
  • Contact: LIN Cuiwu,E-mail:Lincuiwu@163.com E-mail:Lincuiwu@163.com
  • Supported by:
    Supported by the National Natural Science Foundation of China(No.21362001), the Project of the Guangxi Key Laboratory of Traditional Chinese Medicine Quality Standards, China(No.guizhongzhongkai201104) and the High Level Innovation Team and Outstanding Scholar Project of Guangxi Institutions of Higher Education, China(No.guijiaoren[2014]49).

摘要: Three novel L-histidine amide derivatives were synthesized and the corresponding chemical structures were characterized by means of melting point analysis, IR, MS, 1H NMR as well as 13C NMR. The coagulation acti- vities of the compounds were evaluated by an MOE(molecular operating environment) docking technique and coagulation test. The results obtained from molecular docking show that the interactions between the compounds and thrombin exhibit procoagulant activity in combination with an improved combinatory effect. Moreover, the results of in vitro coagulation tests show that the L-histidine amide derivatives feature coagulant activities in common coagulation pathways. Compared with the blank control group, the optimal shortening rates of compounds 13 were 39.08%(0.5 mmol/L), 22.94%(1.0 mmol/L) and 15.38%(0.0625 mmol/L), respectively.

关键词: L-Histidine amide derivative, Molecular docking, Coagulation test

Abstract: Three novel L-histidine amide derivatives were synthesized and the corresponding chemical structures were characterized by means of melting point analysis, IR, MS, 1H NMR as well as 13C NMR. The coagulation acti- vities of the compounds were evaluated by an MOE(molecular operating environment) docking technique and coagulation test. The results obtained from molecular docking show that the interactions between the compounds and thrombin exhibit procoagulant activity in combination with an improved combinatory effect. Moreover, the results of in vitro coagulation tests show that the L-histidine amide derivatives feature coagulant activities in common coagulation pathways. Compared with the blank control group, the optimal shortening rates of compounds 13 were 39.08%(0.5 mmol/L), 22.94%(1.0 mmol/L) and 15.38%(0.0625 mmol/L), respectively.

Key words: L-Histidine amide derivative, Molecular docking, Coagulation test